A former uber-capitalist hedge manager who gouged the price of an AIDS drug because he could is about to have his own business gouged, courtesy of the free market.

Reviled Turing Pharmaceutical CEO Martin Skreli bought last month only to spike its price from $13.50 to $750 per pill.

Now a drug compounding company called Imprimis announced Thursday that it will sell a much cheaper alternative to the pharmaceutical. The competing drug, which contains the same active ingredients as Turing’s Daraprim, will cost $99 for a 100-capsule bottle — just under $1 per pill.

Daraprim is a prescription drug used to treat a rare parasitic infection in people with weakened immune systems, most notably those who have AIDS. Read more…

More about Business and Turing Pharmaceuticals

View original – 

Competitor undercuts hedge fund bro by selling AIDS drug for $1 a pill